Detail akcie Stryker online

Business Summary: Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Stryker Corp revenues increased 11% to $11.89B. Net income decreased 5% to $1.54B. Revenues reflect Orthopaedics segment increase from $2.15B to $4.61B, MedSurg and Neurotechnology segment increase of 17% to $7.28B, United States segment increase of 13% to $8.99B, International segment increase of 7% to $2.89B. Net income was offset by Corporate and Other segment loss increase of 53% to $1.41B.